摘要:
sci-hub.st 参考文章(6)
David A Grimes, LaShawn B. Jones, Laureen M Lopez, Kenneth F Schulz, Oral contraceptives for functional ovarian cysts Cochrane Database of Systematic Reviews. ,vol. 114, ,(2014) , 10.1002/14651858.CD006134.PUB5
J. BAILEY, A. TAILOR, R. NAIK, A. LOPES, K. GODFREY, H.M. HATEM, J. MONAGHAN, Risk of malignancy index for referral of ovarian cancer cases to a tertiary center: does it identify the correct cases? International Journal of Gynecological Cancer. ,vol. 16, pp. 30- 34 ,(2006) , 10.1111/J.1525-1438.2006.00468.X
Richard G. Moore, D. Scott McMeekin, Amy K. Brown, Paul DiSilvestro, M. Craig Miller, W. Jeffrey Allard, Walter Gajewski, Robert Kurman, Robert C. Bast, Steven J. Skates, A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass Gynecologic Oncology. ,vol. 112, pp. 40- 46 ,(2009) , 10.1016/J.YGYNO.2008.08.031
M. Canis, R. Botchorishvili, H. Manhes, A. Wattiez, G. Mage, JL Pouly, MA Bruhat, Management of adnexal masses: role and risk of laparoscopy. Seminars in Surgical Oncology. ,vol. 19, pp. 28- 35 ,(2000) , 10.1002/1098-2388(200007/08)19:1<28::AID-SSU5>3.0.CO;2-C
Michel Canis, Benoit Rabischong, Celine Houlle, Revaz Botchorishvili, Kris Jardon, Antoine Safi, Arnaud Wattiez, Gérard Mage, Jean Luc Pouly, Maurice Antoine Bruhat, Laparoscopic management of adnexal masses: a gold standard? Current Opinion in Obstetrics & Gynecology. ,vol. 14, pp. 423- 428 ,(2002) , 10.1097/00001703-200208000-00010
I. JACOBS, D. ORAM, J. FAIRBANKS, J. TURNER, C. FROST, J. G. GRUDZINSKAS, A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer British Journal of Obstetrics and Gynaecology. ,vol. 97, pp. 922- 929 ,(1990) , 10.1111/J.1471-0528.1990.TB02448.X